Welcome to BioRN

About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant  part in this development.

With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”


November 18, 2014
Merck Advances to Sixth Place in the 2014 Access to Medicine Index
» [mehr]

November 18, 2014
PEPperPRINT and Sciomics announce Partnership Agreement
» [mehr]

November 17, 2014
FDA approves Roche’s Avastin plus chemotherapy to treat women with platinum-resistant recurrent ovarian cancer
» [mehr]


Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.


» Find further future events here

HAE R&D Community

Increase your chances of getting your R&D project funded